Follow on Google News News By Tag * Gvbp * Pwrm * Scii * Picks That Move * Biotech * Stem Cell * Cancer * Diagnosis * Treatments * Growth * Gain * Pharmaceuticals * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | GVBP, PWRM, SCII – biotech and stem cells continue trading green - sourced PicksThatMove.comGenova Biotherapeutics Inc - Power 3 Medical Productions Inc - Stem Cell Therapy International Inc - Join us for more hot stock information at PicksThatMove.com
By: Editorial Staff PicksThatMove.com The hot stock information includes: GVBP, PWRM, SCII Genova Biotherapeutics Inc, is a bioscience company developing therapeutic proteins for use in life-threatening cancers. They have released a string of great news including today announcing they are preparing a patent submission for Prostaganin, a peptide for prostate cancer. With all this great news they continue to trade strong up another 41% trading at $.41 with more than 37.6 million shares trading by early afternoon. Power 3 Medical Productions Inc, uses biostatistical analysis as a diagnostic tool by testing patient body fluids and tissues. They have jumped up 40% today to trade at $.077 with more than 2.7 million shares moving in the early afternoon. Stem Cell Therapy International Inc, continues to refer patients to stem cell treatment facilities and sell stem cell biological solutions to the treatment facilities. They have continued with their upward trend from last week trading up 72% with more than 2.2 million shares changing hands so far today hitting a new 52 week high. To be kept up to date on all of our hot stock information join us at Picks That Move. About PicksThatMove.com: PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. We recommend Due Diligence before investing in any stock. End
Account Email Address Disclaimer Report Abuse
|
|